114 related articles for article (PubMed ID: 28734721)
1. Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care.
Ouyang H; Ma W; Liu F; Yue Z; Fang M; Quan M; Pan Z
Pancreatology; 2017; 17(5):773-781. PubMed ID: 28734721
[TBL] [Abstract][Full Text] [Related]
2. Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases.
Ouyang H; Ma W; Zhang T; Liu F; Zhao L; Fang M; Quan M; Pan Z
Pancreatology; 2018 Dec; 18(8):983-989. PubMed ID: 30287168
[TBL] [Abstract][Full Text] [Related]
3. [Multidisciplinary treatment and survival analysis for 497 cases of pancreatic cancer with liver metastases].
Ouyang HH; Pan ZY; Ma WD; Zhao LJ; Zhang T; Liu F; Quan MM
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):425-30. PubMed ID: 26875916
[TBL] [Abstract][Full Text] [Related]
4. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis.
Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
[TBL] [Abstract][Full Text] [Related]
5. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Partl R; Richtig E; Avian A; Berghold A; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
[TBL] [Abstract][Full Text] [Related]
6. Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?-A propensity score analysis.
Ouyang H; Ma W; Jiang X; Gerdtsson AS; Liu D; Pan Z
Expert Rev Gastroenterol Hepatol; 2023 Apr; 17(4):405-412. PubMed ID: 36803208
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
[TBL] [Abstract][Full Text] [Related]
8. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
[TBL] [Abstract][Full Text] [Related]
9. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
11. Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA.
DeWitt J; Yu M; Al-Haddad MA; Sherman S; McHenry L; Leblanc JK
Gastrointest Endosc; 2010 Feb; 71(2):260-5. PubMed ID: 19922924
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma.
Gray PJ; Wang J; Pawlik TM; Edil BH; Schulick R; Hruban RH; Dao H; Cameron J; Wolfgang C; Herman JM
J Surg Oncol; 2012 Jul; 106(1):66-71. PubMed ID: 22308098
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.
Falchook GS; Wolff RA; Varadhachary GR
Gynecol Oncol; 2008 Mar; 108(3):515-9. PubMed ID: 18164378
[TBL] [Abstract][Full Text] [Related]
15. Predictors of systemic chemotherapy contraindication in pancreatic cancer patients with distant metastasis.
Zhang Y; Dang C; Ma Q; Chen W; Nagata K
Hepatogastroenterology; 2007; 54(73):254-9. PubMed ID: 17419272
[TBL] [Abstract][Full Text] [Related]
16. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
Tachezy M; Gebauer F; Janot M; Uhl W; Zerbi A; Montorsi M; Perinel J; Adham M; Dervenis C; Agalianos C; Malleo G; Maggino L; Stein A; Izbicki JR; Bockhorn M
Surgery; 2016 Jul; 160(1):136-144. PubMed ID: 27048934
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in the operative and palliative treatment of pancreatic cancer.
Talar-Wojnarowska R; Gasiorowska A; Strzelczyk J; Janiak A; Malecka-Panas E
Neoplasma; 2003; 50(5):383-7. PubMed ID: 14628094
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.
Tas F; Aykan F; Alici S; Kaytan E; Aydiner A; Topuz E
Am J Clin Oncol; 2001 Dec; 24(6):547-50. PubMed ID: 11801751
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of veteran patients with pancreatic cancer.
Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
